Related Experiment Videos
Endoscopic therapy for gastroesophageal reflux disease
1Department of Gastroenterology and Hepatopancreatology, Erasme University Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium. hlouis@ulb.ac.be
Minerva Gastroenterologica E Dietologica
|November 12, 2005
Summary
Endoscopic therapies for gastroesophageal reflux disease (GERD) show limited long-term benefits and minimal objective improvement. Further research is needed to establish efficacy and safety before widespread clinical adoption.
Area of Science:
- Gastroenterology
- Minimally Invasive Surgery
Background:
- Endoscopic therapies for GERD have rapidly emerged, with several techniques approved.
- These include injection/bulking, plicating/suturing, and radiofrequency thermal injury.
Purpose of the Study:
- To critically review the efficacy and safety of novel endoscopic therapies for GERD.
- To assess the long-term outcomes and objective reflux reduction.
Main Methods:
- Review of open-label and randomized sham-controlled trials.
- Analysis of short-term and long-term follow-up data.
- Evaluation of objective measures like ambulatory pH-metry.
Main Results:
- Open-label trials showed short-term symptom improvement.
- Randomized trials confirmed clinical efficacy but with less impressive benefits.
- Objective assessment revealed minimal or no reduction in acid reflux.
- Longer-term data for some techniques are disappointing, and safety concerns have arisen.
Conclusions:
- Current endoscopic GERD therapies lack established indications and definitive proof of long-term efficacy and safety.
- Physicians should await robust clinical trial data before widespread use.
- Carefully designed trials are needed to define appropriate patient populations and assess outcomes.